Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Murine model of Zika virus disease developed at UTMBHealth

July 13, 2016

Seqirus ships seasonal influenza vaccines for the U.S. market

July 13, 2016

Emory University develops compounds for HBV infections

July 13, 2016

rTSST-1v vaccine shows potential for the prevention of TSST-1-dependent disease

July 12, 2016

European Investment Bank loan supports R&D activities at Valneva

July 12, 2016

Alios BioPharma announces agents for picornavirus infections

July 11, 2016

Multiple doses of intravenous echinocandin CD-101 safe and well tolerated in phase I study

July 11, 2016

Evotec collaborates with Antibiotic Research UK to tackle antibiotic resistance

July 11, 2016

Gilead Sciences obtains European marketing authorization for Epclusa

July 11, 2016

Valneva develops Zika virus vaccine

July 11, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...